N2OFF shareholders approve acquisition of MitoCareX drug discovery unit

Go back to N2OFF shareholders approve acquisition of MitoCareX drug discovery unit
(NASDAQ: NITO) Delayed: 1.22 --0 (-0%)
Previous Close $1.22    52 Week High
Open $1.22    52 Week Low
Day High $1.22    P/E N/A 
Day Low $1.22    EPS
Volume 56,383       

(NASDAQ: SPRC) Delayed: 5.87 --0 (-0%)
Previous Close $5.87    52 Week High
Open $5.87    52 Week Low
Day High $5.87    P/E N/A 
Day Low $5.87    EPS
Volume 12